{"disease":{"id":"glioma-glioblastoma-multiforme","name":"glioma glioblastoma multiforme"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06118723","title":"The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)","phase":"","overall_status":"RECRUITING","enrollment_count":784,"lead_sponsor_name":"Jasper Gerritsen","has_results":false},{"nct_id":"NCT03722355","title":"Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":712,"lead_sponsor_name":"Radiation Therapy Oncology Group","has_results":false},{"nct_id":"NCT00031538","title":"Genetic Analysis of Brain Tumors","phase":"","overall_status":"TERMINATED","enrollment_count":674,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05271240","title":"Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":432,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT06348693","title":"Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT05839379","title":"Targeted Pediatric High-Grade Glioma Therapy","phase":"","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"Nationwide Children's Hospital","has_results":false},{"nct_id":"NCT05934630","title":"Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors","phase":"","overall_status":"SUSPENDED","enrollment_count":300,"lead_sponsor_name":"Pediatric Brain Tumor Consortium","has_results":false},{"nct_id":"NCT06810544","title":"Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":191,"lead_sponsor_name":"Tango Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05086497","title":"WBSI Guided Personalized Delivery of TTFields","phase":"NA","overall_status":"RECRUITING","enrollment_count":155,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":false},{"nct_id":"NCT05843253","title":"Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Nationwide Children's Hospital","has_results":false},{"nct_id":"NCT02717962","title":"Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Kintara Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05182905","title":"AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":97,"lead_sponsor_name":"Nader Sanai","has_results":false},{"nct_id":"NCT03684811","title":"A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Forma Therapeutics, Inc.","has_results":true},{"nct_id":"NCT06521567","title":"A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":83,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT07391215","title":"5G-PEARL: Paxalisib in Malignant Brain Tumours","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":64,"lead_sponsor_name":"Institute of Cancer Research, United Kingdom","has_results":false},{"nct_id":"NCT02590263","title":"Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT03865355","title":"Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Novosibirsk State University","has_results":false},{"nct_id":"NCT05896449","title":"Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin","phase":"NA","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT02781792","title":"Temozolomide Chronotherapy for High Grade Glioma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT06687681","title":"Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Marzieh Ebrahimi","has_results":false},{"nct_id":"NCT07416188","title":"Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT05023551","title":"Study of DSP-0390 in Patients With Recurrent High-Grade Glioma","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":39,"lead_sponsor_name":"Sumitomo Pharma America, Inc.","has_results":false},{"nct_id":"NCT00879437","title":"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Baylor College of Medicine","has_results":true},{"nct_id":"NCT05954858","title":"Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT03990285","title":"[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Ali Nabavizadeh","has_results":false},{"nct_id":"NCT06011109","title":"Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Aveta Biomics, Inc.","has_results":false},{"nct_id":"NCT03050736","title":"Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Kintara Therapeutics, Inc.","has_results":false},{"nct_id":"NCT01808820","title":"Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Macarena De La Fuente, MD","has_results":false},{"nct_id":"NCT03665545","title":"Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"University Hospital, Geneva","has_results":false},{"nct_id":"NCT05561374","title":"Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":16,"lead_sponsor_name":"Oblato, Inc.","has_results":false},{"nct_id":"NCT06333899","title":"Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Nationwide Children's Hospital","has_results":false},{"nct_id":"NCT03072134","title":"Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT06632236","title":"5G-EMERALD: Amivantamab in Malignant Brain Tumours","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Institute of Cancer Research, United Kingdom","has_results":false},{"nct_id":"NCT03615404","title":"Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Gary Archer Ph.D.","has_results":true},{"nct_id":"NCT04222309","title":"Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)","phase":"PHASE1","overall_status":"SUSPENDED","enrollment_count":10,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT00107003","title":"GW572016 to Treat Recurrent Malignant Brain Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04608812","title":"Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"OncoSynergy, Inc.","has_results":false},{"nct_id":"NCT06650605","title":"Phase 1 Open-label Study of 123I-ATT001 in Subjects With Relapsed Glioblastoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Theragnostics Ltd","has_results":false},{"nct_id":"NCT01281982","title":"(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas","phase":"","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT01902771","title":"Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Edward Ziga","has_results":false},{"nct_id":"NCT06193174","title":"Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT04482933","title":"HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Pediatric Brain Tumor Consortium","has_results":false},{"nct_id":"NCT01117155","title":"A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":43},"guidelines":[],"source":"Drug Landscape verified database"}